Evogene Unit To Launch Medical Cannabis Products In Israeli Market - Quick Facts

(RTTNews) - Canonic Ltd, a unit of Evogene Ltd. (EVGN), announced the pre-launch of its first-generation medical cannabis inflorescence products in Israel. As part of the pre-launch, G-nnovation products will be marketed in Israel to a limited number of licensed patients through Telepharma pharmacy, the company said. Full commercial launch in Israel is anticipated in 2022.

Ofer Haviv, Chairman of Canonic and CEO & President of Evogene, said: "This milestone was achieved, in part, by using Evogene's platform with its unique computational capabilities in the field of genomics, namely the GeneRator AI tech engine."